Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2912099834', 'doi': 'https://doi.org/10.7326/acpj201902190-015', 'title': 'In high-risk T2DM, canagliflozin reduced CV events regardless of baseline renal function', 'display_name': 'In high-risk T2DM, canagliflozin reduced CV events regardless of baseline renal function', 'publication_year': 2019, 'publication_date': '2019-02-18', 'ids': {'openalex': 'https://openalex.org/W2912099834', 'doi': 'https://doi.org/10.7326/acpj201902190-015', 'mag': '2912099834', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/30776804'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.7326/acpj201902190-015', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S119722071', 'display_name': 'Annals of Internal Medicine', 'issn_l': '0003-4819', 'issn': ['0003-4819', '1539-3704'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316812', 'host_organization_name': 'American College of Physicians', 'host_organization_lineage': ['https://openalex.org/P4310316812'], 'host_organization_lineage_names': ['American College of Physicians'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'letter', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5078477384', 'display_name': 'William G. Herrington', 'orcid': 'https://orcid.org/0000-0003-1172-8243'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'William G. Herrington', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5070127648', 'display_name': 'Doreen Zhu', 'orcid': 'https://orcid.org/0000-0002-8470-8430'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Doreen Zhu', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5088900128', 'display_name': 'Richard Haynes', 'orcid': 'https://orcid.org/0000-0002-1179-0023'}, 'institutions': [{'id': 'https://openalex.org/I90344618', 'display_name': 'Medical Research Council', 'ror': 'https://ror.org/03x94j517', 'country_code': 'GB', 'type': 'government', 'lineage': ['https://openalex.org/I4210087105', 'https://openalex.org/I90344618']}, {'id': 'https://openalex.org/I40120149', 'display_name': 'University of Oxford', 'ror': 'https://ror.org/052gg0110', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I40120149']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Richard Haynes', 'raw_affiliation_strings': ['Medical Research Council–Population Health Research UnitUniversity of OxfordOxford, England, UK'], 'affiliations': [{'raw_affiliation_string': 'Medical Research Council–Population Health Research UnitUniversity of OxfordOxford, England, UK', 'institution_ids': ['https://openalex.org/I90344618', 'https://openalex.org/I40120149']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': None, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 61}, 'biblio': {'volume': '170', 'issue': '4', 'first_page': 'JC15', 'last_page': 'JC15'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10401', 'display_name': 'Diabetes Treatment and Management', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2712', 'display_name': 'Endocrinology, Diabetes and Metabolism'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10401', 'display_name': 'Diabetes Treatment and Management', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2712', 'display_name': 'Endocrinology, Diabetes and Metabolism'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10839', 'display_name': 'Pancreatic function and diabetes', 'score': 0.9915, 'subfield': {'id': 'https://openalex.org/subfields/2746', 'display_name': 'Surgery'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10854', 'display_name': 'Bipolar Disorder and Treatment', 'score': 0.9606, 'subfield': {'id': 'https://openalex.org/subfields/2738', 'display_name': 'Psychiatry and Mental health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/empagliflozin', 'display_name': 'Empagliflozin', 'score': 0.8744182}, {'id': 'https://openalex.org/keywords/canagliflozin', 'display_name': 'Canagliflozin', 'score': 0.7285137}, {'id': 'https://openalex.org/keywords/dapagliflozin', 'display_name': 'Dapagliflozin', 'score': 0.5663399}, {'id': 'https://openalex.org/keywords/declaration-of-helsinki', 'display_name': 'Declaration of Helsinki', 'score': 0.4330524}], 'concepts': [{'id': 'https://openalex.org/C2775887513', 'wikidata': 'https://www.wikidata.org/wiki/Q5373824', 'display_name': 'Empagliflozin', 'level': 4, 'score': 0.8744182}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.8567636}, {'id': 'https://openalex.org/C2777451236', 'wikidata': 'https://www.wikidata.org/wiki/Q5030940', 'display_name': 'Canagliflozin', 'level': 4, 'score': 0.7285137}, {'id': 'https://openalex.org/C159641895', 'wikidata': 'https://www.wikidata.org/wiki/Q108377937', 'display_name': 'Renal function', 'level': 2, 'score': 0.6022035}, {'id': 'https://openalex.org/C2777422806', 'wikidata': 'https://www.wikidata.org/wiki/Q409898', 'display_name': 'Dapagliflozin', 'level': 4, 'score': 0.5663399}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.5626877}, {'id': 'https://openalex.org/C2908647359', 'wikidata': 'https://www.wikidata.org/wiki/Q2625603', 'display_name': 'Population', 'level': 2, 'score': 0.52114296}, {'id': 'https://openalex.org/C2775998707', 'wikidata': 'https://www.wikidata.org/wiki/Q777473', 'display_name': 'Declaration of Helsinki', 'level': 4, 'score': 0.4330524}, {'id': 'https://openalex.org/C512399662', 'wikidata': 'https://www.wikidata.org/wiki/Q3505712', 'display_name': 'Family medicine', 'level': 1, 'score': 0.41677347}, {'id': 'https://openalex.org/C555293320', 'wikidata': 'https://www.wikidata.org/wiki/Q12206', 'display_name': 'Diabetes mellitus', 'level': 2, 'score': 0.3858089}, {'id': 'https://openalex.org/C2777180221', 'wikidata': 'https://www.wikidata.org/wiki/Q3025883', 'display_name': 'Type 2 diabetes', 'level': 3, 'score': 0.37216422}, {'id': 'https://openalex.org/C134018914', 'wikidata': 'https://www.wikidata.org/wiki/Q162606', 'display_name': 'Endocrinology', 'level': 1, 'score': 0.2668363}, {'id': 'https://openalex.org/C204787440', 'wikidata': 'https://www.wikidata.org/wiki/Q188504', 'display_name': 'Alternative medicine', 'level': 2, 'score': 0.20850703}, {'id': 'https://openalex.org/C68122502', 'wikidata': 'https://www.wikidata.org/wiki/Q764527', 'display_name': 'Informed consent', 'level': 3, 'score': 0.12734526}, {'id': 'https://openalex.org/C142724271', 'wikidata': 'https://www.wikidata.org/wiki/Q7208', 'display_name': 'Pathology', 'level': 1, 'score': 0.09837648}, {'id': 'https://openalex.org/C99454951', 'wikidata': 'https://www.wikidata.org/wiki/Q932068', 'display_name': 'Environmental health', 'level': 1, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D003924', 'descriptor_name': 'Diabetes Mellitus, Type 2', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D000077203', 'descriptor_name': 'Sodium-Glucose Transporter 2 Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D000068896', 'descriptor_name': 'Canagliflozin', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007004', 'descriptor_name': 'Hypoglycemic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007668', 'descriptor_name': 'Kidney', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.7326/acpj201902190-015', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S119722071', 'display_name': 'Annals of Internal Medicine', 'issn_l': '0003-4819', 'issn': ['0003-4819', '1539-3704'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316812', 'host_organization_name': 'American College of Physicians', 'host_organization_lineage': ['https://openalex.org/P4310316812'], 'host_organization_lineage_names': ['American College of Physicians'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/30776804', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3', 'score': 0.75}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 4, 'referenced_works': ['https://openalex.org/W2424539745', 'https://openalex.org/W2750589886', 'https://openalex.org/W2772844083', 'https://openalex.org/W2898388822'], 'related_works': ['https://openalex.org/W3167014227', 'https://openalex.org/W3119912105', 'https://openalex.org/W3045874509', 'https://openalex.org/W3025178389', 'https://openalex.org/W3008828026', 'https://openalex.org/W2975677680', 'https://openalex.org/W2621360628', 'https://openalex.org/W2600856845', 'https://openalex.org/W2192206197', 'https://openalex.org/W2118342742'], 'abstract_inverted_index': {'ACP': [0], 'Journal': [1], 'Club19': [2], 'February': [3, 331, 338, 360, 365], '2019In': [4], 'high-risk': [5], 'T2DM,': [6], 'canagliflozin': [7, 120], 'reduced': [8], 'CV': [9], 'events': [10], 'regardless': [11], 'of': [12, 34, 57, 80, 149, 203, 210, 316, 375], 'baseline': [13, 123, 258], 'renal': [14, 117, 211], 'functionWilliam': [15], 'G.': [16, 25], 'Herrington,': [17, 26], 'MD,': [18], 'Doreen': [19, 48], 'Zhu,': [20, 49], 'MBChB,': [21], 'Richard': [22, 71], 'Haynes,': [23, 72], 'DMWilliam': [24], 'MDMedical': [27], 'Research': [28, 31, 51, 54, 74, 77, 310, 313], 'Council–Population': [29, 52, 75, 311], 'Health': [30, 53, 76, 312], 'Unit,': [32, 55, 78, 314], 'University': [33, 56, 79, 315], 'Oxford,': [35, 36, 58, 59, 81, 82, 317, 318], 'England,': [37, 60, 83, 319], 'UK': [38, 61, 84, 320], '(W.G.H.,': [39, 62, 85, 321], 'D.Z.,': [40, 63, 86, 322], 'R.H.)Search': [41, 64, 87], 'for': [42, 65, 88, 278, 294], 'more': [43, 66, 89], 'papers': [44, 67, 90], 'by': [45, 68, 91, 282, 372], 'this': [46, 69, 92], 'author,': [47, 70], 'MBChBMedical': [50], 'DMMedical': [73], 'authorAuthor,': [93], 'Article,': [94, 305], 'and': [95, 116, 147, 177, 218, 243, 257, 306], 'Disclosure': [96, 307], 'Informationhttps://doi.org/10.7326/ACPJ201902190-015': [97], 'SectionsAboutFull': [98], 'TextPDF': [99], 'ToolsAdd': [100], 'to': [101, 122], 'favoritesDownload': [102], 'CitationsTrack': [103], 'CitationsPermissions': [104], 'ShareFacebookTwitterLinkedInRedditEmail': [105], 'Source': [106], 'CitationNeuen': [107], 'BL,': [108], 'Ohkuma': [109], 'T,': [110], 'Neal': [111, 234], 'B,': [112, 235], 'et': [113, 141, 171, 199, 236, 274], 'al.': [114, 200, 275], 'Cardiovascular': [115], 'outcomes': [118, 179, 281], 'with': [119, 221, 248, 288], 'according': [121], 'kidney': [124, 150, 290], 'function.': [125], 'Circulation.': [126], '2018;138:1537-50.': [127], 'https://pubmed.ncbi.nlm.nih.gov/29941478Clinical': [128], 'Impact': [129], 'RatingsGIM/FP/GP:': [130], 'Cardiology:': [131], 'Endocrinology:': [132], 'Nephrology:': [133], 'References1': [134], 'Wanner': [135], 'C,': [136], 'Inzucchi': [137], 'SE,': [138], 'Lachin': [139], 'JM,': [140], 'al;': [142, 172, 237], 'EMPA-REG': [143], 'OUTCOME': [144], 'Investigators.': [145, 175], 'Empagliflozin': [146], 'progression': [148], 'disease': [151, 344], 'in': [152, 180, 246, 286], 'type': [153, 181], '2': [154, 182, 355], 'diabetes.': [155, 183], 'N': [156, 184], 'Engl': [157, 185], 'J': [158, 186, 261], 'Med.': [159, 187], '2016;375:323-34.': [160], '[PMID:': [161, 189, 226, 264], '27299675]': [162], 'Google': [163, 191, 228, 266, 302], 'Scholar2': [164], 'Wiviott': [165], 'SD,': [166], 'Raz': [167], 'I,': [168, 198], 'Bonaca': [169], 'MP,': [170], 'DECLARE-TIMI': [173], '58': [174], 'Dapagliflozin': [176], 'cardiovascular': [178], '2019;380:347-57.': [188], '30415602]': [190], 'Scholar3': [192], 'Cherney': [193], 'DZ,': [194], 'Cooper': [195], 'ME,': [196], 'Tikkanen': [197], 'Pooled': [201], 'analysis': [202], 'phase': [204], 'III': [205], 'trials': [206], 'indicate': [207], 'contrasting': [208], 'influences': [209], 'function': [212], 'on': [213, 329], 'blood': [214], 'pressure,': [215], 'body': [216], 'weight,': [217], 'HbA1c': [219], 'reductions': [220], 'empagliflozin.': [222], 'Kidney': [223, 299], 'Int.': [224], '2018;93:231-44.': [225], '28860019]': [227], 'Scholar4': [229], 'Jardine': [230], 'MJ,': [231], 'Mahaffey': [232], 'KW,': [233], 'CREDENCE': [238], 'study': [239, 254], 'investigators.': [240], 'The': [241, 276], 'Canagliflozin': [242], 'Renal': [244], 'Endpoints': [245], 'Diabetes': [247], 'Established': [249], 'Nephropathy': [250], 'Clinical': [251], 'Evaluation': [252], '(CREDENCE)': [253], 'rationale,': [255], 'design,': [256], 'characteristics.': [259], 'Am': [260], 'Nephrol.': [262], '2017;46:462-72.': [263], '29253846]': [265], 'Scholar5': [267], 'Herrington': [268], 'WG,': [269], 'Preiss': [270], 'D,': [271], 'Haynes': [272], 'R,': [273], 'potential': [277], 'improving': [279], 'cardio-renal': [280], 'sodium–glucose': [283], 'co-transporter-2': [284], 'inhibition': [285], 'people': [287], 'chronic': [289], 'disease:': [291], 'a': [292], 'rationale': [293], 'the': [295], 'EMPA-KIDNEY': [296], 'study.': [297], 'Clin': [298], 'J.': [300], '2018;11:749-61.': [301], 'Scholar': [303], 'Author,': [304], 'InformationAffiliations:': [308], 'Medical': [309], 'R.H.)This': [323], 'article': [324], 'was': [325], 'published': [326], 'at': [327], 'Annals.org': [328], '5': [330], '2019.': [332], 'PreviousarticleNextarticle': [333], 'Advertisement': [334], 'FiguresReferencesRelatedDetails': [335], 'Metrics': [336], '19': [337, 359, 364], '2019Volume': [339], '170,': [340], 'Issue': [341, 362], '4Page:': [342], 'JC15KeywordsCardiovascular': [343], 'riskEstimated': [345], 'glomerular': [346], 'filtration': [347], 'rateHazard': [348], 'ratioMyocardial': [349], 'infarctionRenal': [350], 'diseasesRenal': [351], 'failureStandard': [352], 'deviationSystolic': [353], 'pressureType': [354], 'diabetesVascular': [356], 'diseases': [357], 'ePublished:': [358], '2019': [361, 366, 371], 'Published:': [363], 'Copyright': [367], '&': [368], 'PermissionsCopyright': [369], '©': [370], 'American': [373], 'College': [374], 'Physicians.': [376], 'All': [377], 'Rights': [378], 'Reserved.PDF': [379], 'downloadLoading': [380], '...': [381]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2912099834', 'counts_by_year': [], 'updated_date': '2024-12-23T09:37:21.201861', 'created_date': '2019-02-21'}